normal human reference plasma (Precision Biologic Inc)
90
Structured Review
Precision Biologic Inc
normal human reference plasma
Normal Human Reference Plasma, supplied by Precision Biologic Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/reference+normal+human+plasma/pooled+normal+human+plasma/pmc12077799-132-16-20
Average 90 stars, based on 1 article reviews
Normal Human Reference Plasma, supplied by Precision Biologic Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/reference+normal+human+plasma/pooled+normal+human+plasma/pmc12077799-132-16-20
Average 90 stars, based on 1 article reviews
normal human reference plasma - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Clinical Proteomics:Article Title: Measuring factor VIII activity in samples from patients treated with N8-GP (Esperoct ® ; turoctocog alfa pegol) during the pathfinder clinical trials programme. Article Snippet: FVIII activity in samples taken at various time points from 21 patients treated with N8-GP (Esperoct®; turoctocog alfa pegol) during the pathfinder clinical trial programme was assessed and compared using different assay methods.. FVIII activity measurements in samples from patients treated with N8-GP were similar using chromogenic assays, regardless of calibration method or kit/ analyser combination.. FVIII activity measurements using one-stage aPTT-based assays were slightly lower when calibrated using normal human plasma (NHP) compared with a product-specific standard; this difference may be partially attributable to differences in the aPTT reagent/ analyser combinations used to perform the measurements. Article Title: Aging and ABO blood type influence VWF and FVIII levels through interrelated mechanisms Article Snippet: .. Article Title: Endogenous fibrinolysis facilitates clot retraction in vivo. Article Snippet: The fluorogenic substrates used to quantify recombinant human tPA activity after dialysis were tPA SpectroFluor 444FL substrate from American Diagnostica was (ADF Biomedical, France) and Boc-L-(p-F) FPR-ANSN-H-C2H5 from US Biological Life Sciences (MA, USA). .. Article Title: Pediatric Acquired von Willebrand Disease With Berlin Heart Excor Ventricular Assist Device Support. Article Snippet: Background: The balance of hemostasis and anticoagulation is a concern for patients dependent upon ventricular assist devices (VADs).. Bleeding is a common complication with both shortand long-term use of these devices.. A better understanding of the risk factors and etiologies of bleeding associated with these devices is needed and could improve the overall results. Article Title: Fragment-based drug discovery for transthyretin kinetic stabilisers using a novel capillary zone electrophoresis method Article Snippet: .. Briefly, test ligand and 125 I-T 4 (Perkin Elmer Inc., Waltham, MA) were mixed with undiluted Concentration Assay:Article Title: Measuring factor VIII activity in samples from patients treated with N8-GP (Esperoct ® ; turoctocog alfa pegol) during the pathfinder clinical trials programme. Article Snippet: FVIII activity in samples taken at various time points from 21 patients treated with N8-GP (Esperoct®; turoctocog alfa pegol) during the pathfinder clinical trial programme was assessed and compared using different assay methods.. FVIII activity measurements in samples from patients treated with N8-GP were similar using chromogenic assays, regardless of calibration method or kit/ analyser combination.. FVIII activity measurements using one-stage aPTT-based assays were slightly lower when calibrated using normal human plasma (NHP) compared with a product-specific standard; this difference may be partially attributable to differences in the aPTT reagent/ analyser combinations used to perform the measurements. other:Article Title: Population pharmacokinetics of recombinant factor VIII Fc fusion protein. Article Snippet: Population pharmacokinetics (PK) of FVIII activity‐time profiles following recombinant factor VIII Fc fusion protein (rFVIIIFc) and recombinant factor VIII (rFVIII) dosing were evaluated in previously treated patients with severe hemophilia A (from two clinical trials).. Potential covariates that may be determinants of variability in FVIII activity were identified.. A 2‐compartment model adequately described the PK of both compounds. vonWillebrand Factor (VWF) concentration was the major covariate for rFVIIIFc clearance, reflecting its protective role in FVIII activity clearance. Article Title: Factor VIII chimeric and hybrid polypeptides, and methods of use thereof Article Snippet: FVIII activity was measured by the one-stage clotting (aPTT) assay on a Siemens BCS-XP analyzer using commercial reagents (Dade Actin FSL) with calibration against a Article Title: Quantitative and qualitative changes of von Willebrand factor and their impact on mortality in patients with end-stage kidney disease Article Snippet: von Willebrand factor (vWF) antigen levels are elevated in patients with end-stage kidney disease (ESKD).. We determined the quantitative and qualitative abnormalities of vWF and factors influencing vWF proteolysis in participants with ESKD compared with age-matched controls and determined the association between abnormalities in vWF and mortality over 4 years of follow-up. vWF : Ag and von Willebrand factor propeptide (vWFpp) levels, vWF functional activity (vWF :RCo), vWF multimer profiles, ADAMTS-13, thrombospondin 1 (TSP-1), and interleukin 6 (IL-6) were evaluated before and after a single hemodialysis treatment in 55 individuals with vascular disease and an age-matched group of controls (n U 21). vWF : Ag and vWF activity were significantly higher in the ESKD patients and levels increased further following the dialysis procedure.. The percentage of high molecular weight multimers (%HMWMs) was significantly elevated in the ESKD patients compared with controls. Lysis:Article Title: Endogenous fibrinolysis facilitates clot retraction in vivo. Article Snippet: The fluorogenic substrates used to quantify recombinant human tPA activity after dialysis were tPA SpectroFluor 444FL substrate from American Diagnostica was (ADF Biomedical, France) and Boc-L-(p-F) FPR-ANSN-H-C2H5 from US Biological Life Sciences (MA, USA). .. |